Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"... Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"). A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize the company's product development programs. Mehr anzeigen
Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering PR Newswire GREENWOOD VILLAGE, Colo., April 21, 2014 GREENWOOD VILLAGE, Colo., April 21, 2014...
Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market PR Newswire GREENWOOD VILLAGE, Colo., May 17, 2011 GREENWOOD VILLAGE, Colo., May 17, 2011 /PRNewswire/ -- Ampio...
Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement PR Newswire GREENWOOD VILLAGE, Colo., April 19, 2011 GREENWOOD VILLAGE, Colo...
Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011 PR Newswire GREENWOOD VILLAGE, Colo., April 1, 2011 GREENWOOD VILLAGE, Colo., April...
CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc. PR Newswire GREENWOOD VILLAGE, Colo., Aug. 3 GREENWOOD VILLAGE, Colo., Aug. 3...
Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc. PR Newswire GREENWOOD VILLAGE, Colo., July 27 GREENWOOD VILLAGE, Colo., July 27 /PRNewswire-FirstCall/ -- Ampio...
Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™ PR Newswire GREENWOOD VILLAGE, Colo., July 21 GREENWOOD VILLAGE, Colo., July 21 /PRNewswire-FirstCall/ -- Ampio...
Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer PR Newswire GREENWOOD VILLAGE, Colo., May 10 GREENWOOD VILLAGE, Colo., May 10 /PRNewswire-FirstCall/ -- Ampio...
Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc. PR Newswire GREENWOOD VILLAGE, Colo., April 22 GREENWOOD VILLAGE, Colo., April 22 /PRNewswire-FirstCall/ -- Ampio Pharmaceuticals, Inc. (OTC...
Ampio Pharmaceuticals, Inc. Appoints New Independent Director PR Newswire GREENWOOD VILLAGE, Colo., April 14 GREENWOOD VILLAGE, Colo., April 14 /PRNewswire-FirstCall/ -- Ampio Pharmaceuticals...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0021 | 420 | 0.0005 | 0.0026 | 0.0005 | 777 | 0.0026 | CS |
| 4 | -0.0725 | -96.5379494008 | 0.0751 | 0.0751 | 0.0005 | 1653 | 0.01051255 | CS |
| 12 | 0.0004 | 18.1818181818 | 0.0022 | 0.0751 | 0.0004 | 1639 | 0.00509431 | CS |
| 26 | -0.1274 | -98 | 0.13 | 0.45 | 1.0E-6 | 2251 | 0.03979134 | CS |
| 52 | -0.1474 | -98.2666666667 | 0.15 | 0.56 | 1.0E-6 | 4247 | 0.19542985 | CS |
| 156 | -2.7474 | -99.9054545455 | 2.75 | 2.75 | 1.0E-6 | 759795 | 0.02419945 | CS |
| 260 | -0.0029 | -52.7272727273 | 0.0055 | 2.75 | 1.0E-6 | 731654 | 0.02419945 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
